Navigation Links
Americans Not Interested In Choosing Sex Of Child: Survey

A nationwide survey conducted among Americans has revealed that most of them prefer leaving determination of their child's sex to a mere chance. The results of the study may not be applicable to other countries, // where concerns about sex selection may be prevalent, leading to imbalance of the sex ratio.

'We found that only eight percent of people would use pre-implantation sex selection for non-medical reasons,' said Tarun Jain, assistant professor of reproductive endocrinology and infertility at the University of Illinois at Chicago (UIC) and senior author of the study report.

The findings, published in the February issue of the journal Fertility and Sterility, are the result of a cross-sectional, web-based survey of 1,197 people (587 men and 610 women) aged between 18 and 45 years, a UIC statement said.

In the study, the first to examine the demand and preferences for sex selection among the US population, 77 percent who wanted more than one child indicated they either preferred an equal number of boys and girls or had no preference as to the sex of their children.

Pre-conception sex selection using sperm-separation technology is currently available in the US as part of a government-approved clinical trial. The technique is not without controversy, but is expected to become more readily available to consumers at the completion of that trial.

The marketing and increased availability of the technology poses moral, legal and social issues. Some fear that sex selection may disrupt the natural sex ratio and contribute to gender discrimination.

'So far, all of the ethical discussions about sex selection have focused on 'what if' scenarios without any legitimate data,' Jain said. 'This study should provide a legitimate framework to better lead the discussion about the realistic implications of sex selection technology.'

Sperm separation requires patients to provide a sperm sample and un dergo an average of three to five cycles of intrauterine insemination at a fertility centre, at a cost of approximately $2,500 per attempt.

The survey found that while the majority of respondents would not choose the sex of their child under these trying conditions, most would still not use the technology even under less demanding circumstances.

Only 12 percent would use sex selection technology if it were available in any doctor's office, if it required only a single cycle of intrauterine insemination, and if it were covered by health insurance.

Even if it were possible to choose the sex of a child simply by taking a 'blue pill' for a boy or a 'pink pill' for a girl, only 18 percent of respondents indicated they would do so. The rest were opposed or undecided.

'Perhaps this speaks to the fact that people still want to leave things up chance and not rely on science for everything,' said Jain.

In an earlier study, Jain and colleagues had reported that 40 percent of women being treated for infertility would choose the sex of their next child if given the option.

The discrepancy between the two studies is significant but not surprising, Jain said. Infertile couples may feel they have only one chance to have a child, while the general population assumes the opportunity for more children.

'This study should ease the fears of some of people who believe that sex selection technology will become widespread when it is readily available in the United States,' said Jain. 'There is no evidence that the technology will have a significant impact on the natural sex selection ratio.'

Edited IANS
'"/>




Related medicine news :

1. Poll Finds Many Americans Misinformed About Cancer
2. Poll Finds Many Americans Misinformed About Cancer
3. Hypertension Drug of Choice for African Americans
4. 38 million Americans including 14 million children left to combat hunger
5. Americans Consume Far Too Much Salt and Sodium
6. Americans Growing Out Of Shape
7. Rise in Stress among Americans
8. Home Remedies More Used By Blacks And Native Americans
9. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
10. Aspirin, Not Used By African Americans And Diabetics To Prevent Heat Problems
11. Americans Avoiding Risky Foods
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... 26, 2016 , ... Dr. James Maisel will present on ... Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public Library. The ... Group of New York , is a Board Certified ophthalmologist who completed his ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life Science Logistics ... organization has earned its ISO 13485 certification, indicating the company’s quality control system ... and policies associated with ISO quality standard 13485. , BSI Group America, ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... multitude of activities from daily practices, arts & crafts, discussions, and games all ... East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, collegiate sport yoga ...
(Date:5/26/2016)... ... 26, 2016 , ... Power Systems, a leading developer and ... Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ Education ... hour interactive course to qualify participants as certified PowerWave trainers. , PowerWave ...
(Date:5/26/2016)... ... ... A health conscious snack that doesn't sacrifice taste? It's possible! In one ... buzz in the protein product community by offering an alternative to the traditional bar ... with 11 grams of protein and made from a healthy blend of high quality ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... NEW YORK , May 25, 2016 ... Device Market Size, Share, Development, Growth and Demand Forecast ... Insulin Syringe, Insulin Pump and Others)" published by P&S ... valued at $9,998.3 million in 2015, and it is ... 2016-2022. Based on type, the insulin pump segment is ...
Breaking Medicine Technology: